PHASE I-II EVALUATION OF WEEKLY MITOMYCIN-C (NSC-26980) FOR PATIENTS WITH METASTATIC GI AND BREAST MALIGNANCIES - WITH REVIEW OF RECENT LITERATURE

被引：17

作者：

HUM, GJ ^{[1
]}

BOGDON, DL ^{[1
]}

BATEMAN, JR ^{[1
]}

机构：

[1] UNIV SO CALIF, JOHN WESLEY CTY HOSP, SCH MED, 2825 SO HOPE ST, LOS ANGELES, CA 90007 USA

来源：

关键词：

D O I：

10.1159/000224961

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：236 / 243

页数：8

共 26 条

[1]

ANSFIELD FJ, 1969, CANCER CHEMOTH REP 1, V53, P287

[2]

BAKER LH, 1974, P AM SOC CLIN ONCOL

[3]

BRUCE WR, 1966, JNCI-J NATL CANCER I, V37, P233

[4]

CARTER SK, 1968, CANCER CHEMOTH REP 3, V1, P99

[5]

CARTER SK, 1968, MITOMYCINC NSC26980

[6]

EVANS AE, 1969, CANCER CHEMOTH REP 1, V53, P297

[7]

FRANK W, 1960, CANCER CHEMOTH REP, P114

[8]

GODFREY TE, 1972, CANCER, V29, P1647, DOI 10.1002/1097-0142(197206)29:6<1647::AID-CNCR2820290632>3.0.CO

[9]

2-6

[10]

JACOBS EM, 1970, 10 INT CANC C HOUST